Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IVPMED is a healthcare technology company specializing in AI-powered inhalation systems for medical and research applications. The company's core offerings include the NebSync Nebulizer and ActAir smart inhaler, which utilize artificial intelligence to personalize dosing schedules and optimize drug absorption. IVPMED also provides a HIPAA-compliant Medical Dashboard that allows healthcare professionals to monitor patient adherence and adjust treatments remotely in real-time. By integrating blockchain technology for data integrity, the company supports clinical trials and institutional healthcare with secure, verifiable data. IVPMED operates as a subsidiary of Sixsense Holdings Inc. and is focused on advancing precision medicine in respiratory care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IVPMED.